Gables Capital Management Inc. Viatris Inc Transaction History

Gables Capital Management Inc.

$228 Million
Q3 2025

A detailed history of Gables Capital Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Gables Capital Management Inc. holds 4,175 shares of VTRS stock, worth $44,756. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,175

Previous 4,390 4.9%

Holding current value

$44,756

Previous $39,000 5.13%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$8.74 - $10.69 $1,879 - $2,298	-215 Reduced 4.9%	4,175 $41,000
Q2 2025 Jul 30, 2025	SELL	$7.26 - $9.12 $3,041 - $3,821	-419 Reduced 8.71%	4,390 $39,000
Q4 2024 Feb 07, 2025	SELL	$11.32 - $13.37 $1,120 - $1,323	-99 Reduced 2.02%	4,809 $59,000
Q2 2024 Aug 07, 2024	SELL	$10.05 - $12.02 $1,477 - $1,766	-147 Reduced 2.91%	4,908 $52,000
Q1 2024 May 03, 2024	SELL	$11.27 - $13.53 $1,250 - $1,501	-111 Reduced 2.15%	5,055 $60,000
Q4 2023 Feb 07, 2024	SELL	$8.77 - $10.85 $2,578 - $3,189	-294 Reduced 5.38%	5,166 $55,000
Q2 2023 Aug 02, 2023	BUY	$9.02 - $10.29 $54 - $61	6 Added 0.11%	5,460 $54,000
Q4 2022 Feb 03, 2023	SELL	$8.72 - $11.56 $479 - $635	-55 Reduced 1.0%	5,454 $60,000
Q3 2022 Oct 31, 2022	SELL	$8.48 - $11.13 $203 - $267	-24 Reduced 0.43%	5,509 $47,000
Q2 2022 Jul 18, 2022	SELL	$9.95 - $12.27 $427 - $527	-43 Reduced 0.77%	5,533 $58,000
Q1 2022 May 02, 2022	SELL	$9.81 - $15.4 $510 - $800	-52 Reduced 0.92%	5,576 $61,000
Q2 2021 Aug 03, 2021	SELL	$12.97 - $16.15 $33,332 - $41,505	-2,570 Reduced 31.35%	5,628 $80,000
Q4 2020 Feb 03, 2021	BUY	$14.3 - $18.74 $117,231 - $153,630	8,198 New	8,198 $154,000

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

966M

Call Options Held

7.74M

Put Options Held

2.47M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Viatris Inc Transaction History